Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
51.88
-1.59 (-2.97%)
Mar 3, 2026, 4:00 PM EST - Market closed
Monopar Therapeutics Analyst Ratings
Total Analysts
13
Consensus Rating
Strong Buy
Price Target
$101.42
Upside
+95.49%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $104 | Strong Buy | Reiterates | $104 | +100.46% | Feb 23, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $104 | Strong Buy | Reiterates | $104 | +100.46% | Feb 2, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $100 | Strong Buy | Maintains | $100 | +92.75% | Jan 29, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $104 | Strong Buy | Reiterates | $104 | +100.46% | Jan 14, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $115 | Buy | Initiates | $115 | +121.67% | Jan 9, 2026 |
| Raymond James | Raymond James | Strong Buy → Buy Downgrades $142 → $123 | Strong Buy → Buy | Downgrades | $142 → $123 | +137.09% | Nov 14, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $100 | Strong Buy | Maintains | $100 | +92.75% | Nov 13, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $115 | Buy | Initiates | $115 | +121.67% | Nov 10, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $85 → $100 | Strong Buy | Maintains | $85 → $100 | +92.75% | Nov 9, 2025 |
| Barclays | Barclays | Buy Initiates $125 | Buy | Initiates | $125 | +140.94% | Oct 13, 2025 |
| Raymond James | Raymond James | Strong Buy Maintains $80 → $142 | Strong Buy | Maintains | $80 → $142 | +173.71% | Oct 6, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $77 → $115 | Buy | Maintains | $77 → $115 | +121.67% | Oct 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $70 → $105 | Strong Buy | Maintains | $70 → $105 | +102.39% | Sep 29, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $76 → $95 | Buy | Maintains | $76 → $95 | +83.11% | Sep 25, 2025 |
| BTIG | BTIG | Strong Buy Maintains $87 → $104 | Strong Buy | Maintains | $87 → $104 | +100.46% | Sep 25, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $60 → $85 | Strong Buy | Maintains | $60 → $85 | +63.84% | Sep 25, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.